Thursday, November 1, 2012, 6:35 PMMasimo (MASI): Q3 EPS of $0.24 misses by $0.01. Revenue of $112.1M (+14.5% Y/Y) misses by $9M. (PR)
Wednesday, August 1, 2012, 5:06 PMMasimo (MASI): Q2 EPS of $0.27 misses by $0.01. Revenue of $122.8M (+12% Y/Y) beats by $2.8M. (PR)
Friday, June 15, 2012, 12:02 PM
Henry Schein (HSIC +1.3%) says it's inked a distribution agreement with patient care provider Masimo Corporation (MASI +1.8%) to distribute Masimo’s Pronto-7, the only FDA approved small non-invasive device for spot-checking of total hemoglobin, SpO2, pulse rate and perfusion index.
Friday, February 10, 2012, 10:43 AM
Masimo (MASI -3.2%) dips after being cut to Sell from Neutral at Citigroup on on concerns over margin compression and limited adoption of its technology among hospital customers.
Comment![Healthcare, On the Move]
Monday, January 9, 2012, 1:13 PM
Masimo (MASI +1.6%) announces that it landed FDA clearance for a commercial launch of its handheld hemoglobin spot-checking device that can be used to wirelessly print or email test results.
Tuesday, October 25, 2011, 5:08 PM
Masimo (MASI), a maker of patient monitoring systems, gains 2.1% AH in spite of reporting Q3 revenue of $104M (+3 % Y/Y) and EPS $0.24, missing consensus by $5.7M and $0.03. Masimo is also lowering its 2011 EPS guidance to $1.04-$1.06, from a prior range of $1.17-$1.25.
Comment![Healthcare, Earnings, On the Move]
Tuesday, November 2, 2010, 5:25 PMMasimo (MASI): Q3 EPS of $0.28 beats by $0.03. Revenue of $101M (+15.5%) vs. $101M. (PR)